{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T01:09:59Z","timestamp":1789952999542,"version":"4.0.1"},"reference-count":66,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2016,2,25]],"date-time":"2016-02-25T00:00:00Z","timestamp":1456358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0149792","type":"journal-article","created":{"date-parts":[[2016,2,25]],"date-time":"2016-02-25T20:02:06Z","timestamp":1456430526000},"page":"e0149792","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":90,"title":["Analysis of the Putative Role of CR1 in Alzheimer\u2019s Disease: Genetic Association, Expression and Function"],"prefix":"10.1371","volume":"11","author":[{"given":"Maria I.","family":"Fonseca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhui","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee L.","family":"Pierce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Brubaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.","family":"Hauhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Mastroeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth V.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea J.","family":"Tenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,2,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.4049\/jimmunol.1203487","article-title":"Complement in immune and inflammatory disorders: pathophysiological mechanisms","volume":"190","author":"D Ricklin","year":"2013","journal-title":"J Immunol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.it.2008.11.003","article-title":"Complement activation and inhibition: a delicate balance","volume":"30","author":"AP Sjoberg","year":"2009","journal-title":"Trends Immunol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer&apos;s disease","volume":"41","author":"JC Lambert","year":"2009","journal-title":"Nat Genet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/archneurol.2010.147","article-title":"Replication of CLU, CR1, and PICALM associations with alzheimer disease","volume":"67","author":"MM Carrasquillo","year":"2010","journal-title":"Arch Neurol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/archneurol.2010.201","article-title":"Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes","volume":"67","author":"G Jun","year":"2010","journal-title":"Arch Neurol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1093\/hmg\/ddq221","article-title":"Association of CR1, CLU and PICALM with Alzheimer&apos;s disease in a cohort of clinically characterized and neuropathologically verified individuals","volume":"19","author":"JJ Corneveaux","year":"2010","journal-title":"Hum Mol Genet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2013.03.030","article-title":"Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer&apos;s Disease","volume":"153","author":"B Zhang","year":"2013","journal-title":"Cell"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1046\/j.1365-2567.1996.d01-747.x","article-title":"Covalent binding of C3b to tetanus toxin: influence on uptake\/internalization of antigen by antigen-specific and non-specific B cells","volume":"89","author":"MB Villiers","year":"1996","journal-title":"Immunology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.molimm.2008.09.026","article-title":"Complement Receptor 1: disease associations and therapeutic implications","volume":"46","author":"R Khera","year":"2009","journal-title":"Mol Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.4049\/jimmunol.1202451","article-title":"Deciphering complement receptor type 1 interactions with recognition proteins of the lectin complement pathway","volume":"190","author":"M Jacquet","year":"2013","journal-title":"J Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1034\/j.1600-065X.2001.1800110.x","article-title":"Structure-function relationships of complement receptor type 1","volume":"180","author":"M Krych-Goldberg","year":"2001","journal-title":"Immunological Reviews"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.imbio.2011.07.023","article-title":"Complement activation as a biomarker for Alzheimer&apos;s disease","volume":"217","author":"M Aiyaz","year":"2012","journal-title":"Immunobiology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3109\/08923970902845768","article-title":"The structure, genetic polymorphisms, expression and biological functions of complement receptor type 1 (CR1\/CD35)","volume":"31","author":"D Liu","year":"2009","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e34820","DOI":"10.1371\/journal.pone.0034820","article-title":"Lack of evidence from studies of soluble protein fragments that Knops blood group polymorphisms in complement receptor-type 1 are driven by malaria","volume":"7","author":"PB Tetteh-Quarcoo","year":"2012","journal-title":"PLoS ONE"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/mp.2011.24","article-title":"Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b\/C4b binding sites","volume":"17","author":"N Brouwers","year":"2012","journal-title":"Mol Psychiatry"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1093\/hmg\/dds054","article-title":"A coding variant in CR1 interacts with APOE-epsilon4 to influence cognitive decline","volume":"21","author":"BT Keenan","year":"2012","journal-title":"Hum Mol Genet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1365-2249.1998.00549.x","article-title":"Mapping epitopes for 20 monoclonal antibodies to CR1","volume":"112","author":"M Nickells","year":"1998","journal-title":"Clin exp Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000019084","article-title":"Reference typing report for complement receptor 1 (CR1)","volume":"15","author":"JM Moulds","year":"1998","journal-title":"Exp Clin Immunogenet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S1074-7613(00)80356-8","article-title":"Complement receptor type 1 (CR1, CD35) is a receptor for C1q","volume":"7","author":"LB Klickstein","year":"1997","journal-title":"Immunity"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"929803","DOI":"10.1155\/2012\/929803","article-title":"Mannose-binding lectin binds to amyloid beta protein and modulates inflammation","volume":"2012","author":"M Larvie","year":"2012","journal-title":"J Biomed Biotechnol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1006\/exnr.1996.0043","article-title":"Localization and cell association of C1q in Alzheimer&apos;s disease brain","volume":"138","author":"A Afagh","year":"1996","journal-title":"Exp Neurol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"10016","DOI":"10.1073\/pnas.89.21.10016","article-title":"Complement activation by beta-amyloid in Alzheimer disease","volume":"89","author":"J Rogers","year":"1992","journal-title":"Proc Natl Acad Sci"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nm0197-77","article-title":"Aspartate residue 7 in amyloid beta-protein is critical for classical complement pathway activation: implications for Alzheimer&apos;s disease pathogenesis","volume":"3","author":"P Velazquez","year":"1997","journal-title":"Nat Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1084\/jem.188.3.431","article-title":"Complement-dependent proinflammatory properties of the Alzheimer&apos;s disease beta-peptide","volume":"188","author":"BM Bradt","year":"1998","journal-title":"J Exp Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.neurobiolaging.2005.09.043","article-title":"Peripheral clearance of amyloid beta peptide by complement C3-dependent adherence to erythrocytes","volume":"27","author":"J Rogers","year":"2006","journal-title":"Neurobiol Aging"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.4049\/jimmunol.163.9.5056","article-title":"C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion","volume":"163","author":"SW Tas","year":"1999","journal-title":"J Immunol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1365-2249.2007.03355.x","article-title":"Antibody CR1-2B11 recognizes a non-polymorphic epitope of human CR1 (CD35)","volume":"148","author":"CH Chen","year":"2007","journal-title":"Clin exp Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1126\/science.2371562","article-title":"Soluble human complement receptor type 1: In vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis","volume":"249","author":"HF Weisman","year":"1990","journal-title":"Science (New York, N Y)"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1002\/(SICI)1521-4141(199911)29:11<3754::AID-IMMU3754>3.0.CO;2-5","article-title":"Elastase and metalloproteinase activities regulate soluble complement receptor 1 release","volume":"29","author":"S Sadallah","year":"1999","journal-title":"Eur J Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/j.neurobiolaging.2013.03.008","article-title":"Complement receptor 1 coding variant p.Ser1610Thr in Alzheimer&apos;s disease and related endophenotypes","volume":"34","author":"C Van Cauwenberghe","year":"2013","journal-title":"Neurobiol Aging"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0197-4580(96)00006-1","article-title":"Characterization of glial cultures from rapid autopsies of Alzheimer&apos;s and control patients","volume":"17","author":"LF Lue","year":"1996","journal-title":"Neurobiol Aging"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"24754","DOI":"10.1016\/S0021-9258(18)35828-9","article-title":") Cell surface expression of the C3b\/C4b receptor (CR1) protects Chinese hamster ovary cells from lysis by human complement","volume":"267","author":"SC Makrides","year":"1992","journal-title":"J Biol Chem"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1523\/JNEUROSCI.03-06-01289.1983","article-title":"Two types of astrocytes in cultures of developing rat white matter: differences in morphology, surface gangliosides, and growth characteristics","volume":"3","author":"MC Raff","year":"1983","journal-title":"J Neurosci"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/cne.22040","article-title":"Subventricular zone neural progenitors from rapid brain autopsies of elderly subjects with and without neurodegenerative disease","volume":"515","author":"BW Leonard","year":"2009","journal-title":"J Comp Neurol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1474-9726.2010.00556.x","article-title":"Longterm quiescent cells in the aged human subventricular neurogenic system specifically express GFAP-delta","volume":"9","author":"SA van den Berge","year":"2010","journal-title":"Aging Cell"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1172\/JCI111572","article-title":") Human neutrophils increase expression of C3bi as well as C3b receptors upon activation","volume":"74","author":"M Berger","year":"1984","journal-title":"J Clin Invest"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/j.neurobiolaging.2015.01.006","article-title":"Alzheimer&apos;s disease is associated with low density of the long CR1 isoform","volume":"36","author":"R Mahmoudi","year":"2015","journal-title":"Neurobiol Aging"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/ana.22277","article-title":"CR1 is associated with amyloid plaque burden and age-related cognitive decline","volume":"69","author":"LB Chibnik","year":"2011","journal-title":"Ann Neurol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/j.1471-4159.2008.05668.x","article-title":"The complement cascade: Yin-Yang in neuroinflammation\u2014neuro-protection and -degeneration","volume":"107","author":"JJ Alexander","year":"2008","journal-title":"J Neurochem"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"a006346","DOI":"10.1101\/cshperspect.a006346","article-title":"Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature","volume":"2","author":"T Wyss-Coray","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"6457","DOI":"10.1523\/JNEUROSCI.0901-04.2004","article-title":"Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer&apos;s disease","volume":"24","author":"MI Fonseca","year":"2004","journal-title":"J Neurosci"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.4049\/jimmunol.0901005","article-title":"Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer&apos;s disease","volume":"183","author":"MI Fonseca","year":"2009","journal-title":"J Immunol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.nbd.2003.09.010","article-title":"Complement activation in human prion disease","volume":"15","author":"GG Kovacs","year":"2004","journal-title":"Neurobiol Dis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.4049\/jimmunol.1201579","article-title":"Genetic depletion of complement receptors CD21\/35 prevents terminal prion disease in a mouse model of chronic wasting disease","volume":"189","author":"B Michel","year":"2012","journal-title":"J Immunol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/86562","article-title":"Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie","volume":"7","author":"NA Mabbott","year":"2001","journal-title":"Nat Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1523\/JNEUROSCI.0829-08.2008","article-title":"Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia\/macrophage phenotype in amyloid precursor protein transgenic mice","volume":"28","author":"M Maier","year":"2008","journal-title":"J Neurosci"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"13029","DOI":"10.1523\/JNEUROSCI.1698-15.2015","article-title":"Complement C3-Deficient Mice Fail to Display Age-Related Hippocampal Decline","volume":"35","author":"Q Shi","year":"2015","journal-title":"J Neurosci"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1074\/jbc.M112.400168","article-title":"C1q-induced LRP1B and GPR6 Proteins Expressed Early in Alzheimer Disease Mouse Models, Are Essential for the C1q-mediated Protection against Amyloid-beta Neurotoxicity","volume":"288","author":"ME Benoit","year":"2013","journal-title":"J Biol Chem"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1523\/JNEUROSCI.3932-10.2011","article-title":"Complement protein C1q-mediated neuroprotection is correlated with regulation of neuronal gene and microRNA expression","volume":"31","author":"ME Benoit","year":"2011","journal-title":"J Neurosci"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/j.1471-4159.2007.05012.x","article-title":"Complement component C1q inhibits beta-amyloid- and serum amyloid P-induced neurotoxicity via caspase- and calpain-independent mechanisms","volume":"104","author":"K Pisalyaput","year":"2008","journal-title":"J Neurochem"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1471-4159.2009.06494.x","article-title":"C1q enhances microglial clearance of apoptotic neurons and neuronal blebs, and modulates subsequent inflammatory cytokine production","volume":"112","author":"DA Fraser","year":"2010","journal-title":"J Neurochem"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"6175","DOI":"10.4049\/jimmunol.0902232","article-title":"C1q differentially modulates phagocytosis and cytokine responses during ingestion of apoptotic cells by human monocytes, macrophages, and dendritic cells","volume":"183","author":"DA Fraser","year":"2009","journal-title":"J Immunol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.cell.2007.10.036","article-title":"The classical complement cascade mediates CNS synapse elimination","volume":"131","author":"B Stevens","year":"2007","journal-title":"Cell"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.4049\/jimmunol.156.6.2247","article-title":"Identification and characterization of complement C3 receptors on human astrocytes","volume":"156","author":"P Gasque","year":"1996","journal-title":"J Immunol"},{"key":"ref55","first-page":"1247","article-title":"Differential expression of individual complement regulators in the brain and choroid plexus","volume":"79","author":"SK Singhrao","year":"1999","journal-title":"Lab Invest"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1742-2094-3-22","article-title":"Expression of innate immune complement regulators on brain epithelial cells during human bacterial meningitis","volume":"3","author":"C Canova","year":"2006","journal-title":"J Neuroinflammation"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1016\/j.neurobiolaging.2012.07.001","article-title":"Genetic association of CR1 with Alzheimer&apos;s disease: a tentative disease mechanism","volume":"33","author":"LN Hazrati","year":"2012","journal-title":"Neurobiol Aging"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/01.wad.0000165506.60370.94","article-title":"Complement activation in very early Alzheimer disease","volume":"19","author":"H Zanjani","year":"2005","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.4049\/jimmunol.151.3.1702","article-title":"Circulating soluble CR1 (CD35). Serum levels in diseases and evidence for its release by human leukocytes","volume":"151","author":"M Pascual","year":"1993","journal-title":"J Immunol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11239-006-9040-5","article-title":"Low levels of plasma soluble complement receptor type 1 in patients receiving thrombolytic therapy for acute myocardial infarction","volume":"23","author":"G Karthikeyan","year":"2007","journal-title":"J Thromb Thrombolysis"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00702-012-0797-8","article-title":"Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer&apos;s disease","volume":"119","author":"J Daborg","year":"2012","journal-title":"J Neural Transm"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1073\/pnas.80.6.1698","article-title":"Polymorphism of human erythrocyte C3b\/C4b receptor","volume":"80","author":"TR Dykman","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref63","first-page":"74","article-title":"The rate of loss of CR1 from ageing erythrocytes in vivo in normal subjects and SLE patients: no correlation with structural or numerical polymorphisms","volume":"72","author":"F Moldenhauer","year":"1988","journal-title":"Clin exp Immunol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0969-9961(03)00044-5","article-title":"Evidence for peripheral clearance of cerebral Abeta protein following chronic, active Abeta immunization in PSAPP mice","volume":"14","author":"CA Lemere","year":"2003","journal-title":"Neurobiol Dis"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2174\/187152709787601867","article-title":"Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer&apos;s disease","volume":"8","author":"R Deane","year":"2009","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1523\/JNEUROSCI.3407-12.2013","article-title":"Enhanced proteolytic clearance of plasma Abeta by peripherally administered neprilysin does not result in reduced levels of brain Abeta in mice","volume":"33","author":"JR Walker","year":"2013","journal-title":"J Neurosci"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0149792","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T16:23:37Z","timestamp":1718382217000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0149792"}},"subtitle":[],"editor":[{"given":"Mark D.","family":"Zabel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,2,25]]},"references-count":66,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,2,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0149792","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,25]]}}}